Yoon SH - Search Results

1

The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections: a randomized controlled trial.

Park WB, Kim NH, Kim KH, Lee SH, Nam WS, Yoon SH, Song KH, Choe PG, Kim NJ, Jang IJ, Oh MD, Yu KS. Park WB, et al. Among authors: yoon sh. Clin Infect Dis. 2012 Oct;55(8):1080-7. doi: 10.1093/cid/cis599. Epub 2012 Jul 3. Clin Infect Dis. 2012. PMID: 22761409 Clinical Trial.

2

A pharmacokinetic comparison of two voriconazole formulations and the effect of CYP2C19 polymorphism on their pharmacokinetic profiles.

Chung H, Lee H, Han HK, An H, Lim KS, Lee YJ, Cho JY, Yoon SH, Jang IJ, Yu KS. Chung H, et al. Among authors: yoon sh. Drug Des Devel Ther. 2015 May 13;9:2609-16. doi: 10.2147/DDDT.S80066. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 25999694 Free PMC article. Clinical Trial.

3

Early Therapeutic Drug Monitoring of Posaconazole Oral Suspension in Patients With Hematologic Malignancies.

Suh HJ, Kim I, Cho JY, Park SI, Yoon SH, Hwang JH, Bae JY, Lee JO, Koh Y, Song KH, Choe PG, Yu KS, Kim ES, Kim HB, Bang SM, Kim NJ, Song SH, Park WB, Oh MD. Suh HJ, et al. Among authors: yoon sh. Ther Drug Monit. 2018 Feb;40(1):115-119. doi: 10.1097/FTD.0000000000000469. Ther Drug Monit. 2018. PMID: 29189664

4

Effect of CYP2C19 polymorphism on the pharmacokinetics of voriconazole after single and multiple doses in healthy volunteers.

Lee S, Kim BH, Nam WS, Yoon SH, Cho JY, Shin SG, Jang IJ, Yu KS. Lee S, et al. Among authors: yoon sh. J Clin Pharmacol. 2012 Feb;52(2):195-203. doi: 10.1177/0091270010395510. J Clin Pharmacol. 2012. PMID: 21383338 Clinical Trial.

5

Assessment of the pharmacokinetics of co-administered metformin and lobeglitazone, a thiazolidinedione antihyperglycemic agent, in healthy subjects.

Shin D, Kim TE, Yoon SH, Cho JY, Shin SG, Jang IJ, Yu KS. Shin D, et al. Among authors: yoon sh. Curr Med Res Opin. 2012 Jul;28(7):1213-20. doi: 10.1185/03007995.2012.703131. Epub 2012 Jul 2. Curr Med Res Opin. 2012. PMID: 22697273 Clinical Trial.

6

Population pharmacokinetics of theophylline in premature Korean infants.

Kim SE, Kim BH, Lee S, Sohn JA, Kim HS, Cho JY, Yoon SH, Jang IJ, Yu KS, Lim KS. Kim SE, et al. Among authors: yoon sh. Ther Drug Monit. 2013 Jun;35(3):338-44. doi: 10.1097/FTD.0b013e3182866695. Ther Drug Monit. 2013. PMID: 23666573 Clinical Trial.

7

Tolerability and pharmacokinetics of lobeglitazone, a novel peroxisome proliferator-activated receptor-γ agonist, after a single oral administration in healthy female subjects.

Park MK, Kim TE, Kim J, Kim C, Yoon SH, Cho JY, Jang IJ, Yu KS, Lim KS. Park MK, et al. Among authors: yoon sh. Clin Drug Investig. 2014 Jul;34(7):467-74. doi: 10.1007/s40261-014-0197-y. Clin Drug Investig. 2014. PMID: 24802657 Clinical Trial.

8

Pharmacokinetics of the evogliptin/metformin extended-release (5/1,000 mg) fixed-dose combination formulation compared to the corresponding loose combination, and food effect in healthy subjects.

Rhee SJ, Lee S, Yoon SH, Cho JY, Jang IJ, Yu KS. Rhee SJ, et al. Among authors: yoon sh. Drug Des Devel Ther. 2016 Apr 13;10:1411-8. doi: 10.2147/DDDT.S102459. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 27110098 Free PMC article. Clinical Trial.

9

Effectiveness of increasing the frequency of posaconazole syrup administration to achieve optimal plasma concentrations in patients with haematological malignancy.

Park WB, Cho JY, Park SI, Kim EJ, Yoon S, Yoon SH, Lee JO, Koh Y, Song KH, Choe PG, Yu KS, Kim ES, Bang SM, Kim NJ, Kim I, Oh MD, Kim HB, Song SH. Park WB, et al. Among authors: yoon s, yoon sh. Int J Antimicrob Agents. 2016 Jul;48(1):106-110. doi: 10.1016/j.ijantimicag.2016.04.013. Epub 2016 May 12. Int J Antimicrob Agents. 2016. PMID: 27234674

10

A randomized, double-blind, single-dose, two-arm, parallel study comparing pharmacokinetics, immunogenicity and tolerability of branded adalimumab and its biosimilar LBAL in healthy male volunteers.

Park KR, Chung H, Yang SM, Lee S, Yoon SH, Cho JY, Jang IJ, Yu KS. Park KR, et al. Among authors: yoon sh. Expert Opin Investig Drugs. 2017 May;26(5):619-624. doi: 10.1080/13543784.2017.1307339. Epub 2017 Mar 23. Expert Opin Investig Drugs. 2017. PMID: 28290731 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,832 results

Search Page